TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34277328

Group type: EXPERIMENTAL
Intervention: Public healthcare sector claims
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Individual communicators
Number of subjects: 274

Group type: EXPERIMENTAL
Intervention: Laypeople communicators
Number of subjects: 274

Group type: COMPARATOR
Intervention: Private healthcare sector claims
Number of subjects: 274

Group type: COMPARATOR
Intervention: Collective communicators
Number of subjects: 274

Group type: COMPARATOR
Intervention: Expert communicators
Number of subjects: 274
Study: 33447866

Group type: EXPERIMENTAL
Intervention: Needle aspiration with clindamycin for one week postoperatively
Number of subjects: 98

Group type: COMPARATOR
Intervention: Incision drainage
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Needle aspiration
Number of subjects: 98
Study: 32430771

Group type: EXPERIMENTAL
Intervention: Hypopharyngeal packing (HP) during adenotonsillectomy
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control group (no hypopharyngeal packing)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Hypopharyngeal packing (HP)
Number of subjects: 129
Study: 36364801

Group type: EXPERIMENTAL
Intervention: WPH (ERD + 20 g/d WPH)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (ERD)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: WP (ERD + 20 g/d WP)
Number of subjects: 60
Study: 33301158

Group type: EXPERIMENTAL
Intervention: Walking group (required to walk more than 12,000 steps within 6 hours after HSG)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (prohibited from performing high‐intensity exercise)
Number of subjects: 100
Study: 34556273

Group type: EXPERIMENTAL
Intervention: SAPIEN XT TAVR
Number of subjects: 1524

Group type: EXPERIMENTAL
Intervention: SAPIEN 3 TAVR
Number of subjects: 1524

Group type: COMPARATOR
Intervention: SAVR
Number of subjects: 1524
Study: 33412544

Group type: EXPERIMENTAL
Intervention: Ambu Bronchosampler with aScope 4
Number of subjects: 20
Study: 33588527

Group type: EXPERIMENTAL
Intervention: Atabecestat (JNJ-54861911)
Number of subjects: 0
Study: 33970205

Group type: EXPERIMENTAL
Intervention: Medical management after the index stroke (93% of patients with CW)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Endovascular treatment (EVT)
Number of subjects: 30
Study: 32012319

Group type: EXPERIMENTAL
Intervention: Action Observation (AO)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Motor Imagery (MI)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Visual Mirror Feedback (VMF)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 52
Study: 35431038

Group type: EXPERIMENTAL
Intervention: High PEEP with recruitment manoeuvres
Number of subjects: 3837

Group type: COMPARATOR
Intervention: Low PEEP
Number of subjects: 3837
Study: 32761372

Group type: EXPERIMENTAL
Intervention: Aspirin 100 mg once a day (GA100)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Aspirin 160 mg once a day (GA160)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Aspirin 100 mg twice a day (G2A100)
Number of subjects: 59
Study: 35986416

Group type: EXPERIMENTAL
Intervention: Tailored health insurance education intervention with a patient navigator that includes usual care
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual navigation care
Number of subjects: 80
Study: 34479617

Group type: EXPERIMENTAL
Intervention: Intrinsic-foot-muscle exercise combined with lower extremity resistance training
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Extrinsic-foot-muscle exercise combined with lower extremity resistance training
Number of subjects: 120

Group type: COMPARATOR
Intervention: Lower extremity resistance training
Number of subjects: 120
Study: 32984232

Group type: EXPERIMENTAL
Intervention: Immersive aging simulation suit and medication review polypharmacy workshop
Number of subjects: 120

Group type: COMPARATOR
Intervention: Medication review polypharmacy workshop (control)
Number of subjects: 120
Study: 32345116

Group type: EXPERIMENTAL
Intervention: Dermoscopy
Number of subjects: 133

Group type: COMPARATOR
Intervention: Naked eye
Number of subjects: 133
Study: 32646482

Group type: EXPERIMENTAL
Intervention: myo-inositol and folic acid (4000 mg myo-inositol and 400 mcg folic acid daily)
Number of subjects: 160

Group type: COMPARATOR
Intervention: folic acid alone (400 mcg folic acid daily)
Number of subjects: 160
Study: 33640311

Group type: EXPERIMENTAL
Intervention: Bioactive sirolimus-eluting stent (COMBO)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Polymer-free biolimus-eluting stent (BioFreedom)
Number of subjects: 60
Study: 33279373

Group type: EXPERIMENTAL
Intervention: Maintenance treatment (MT)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Dose-reduction/discontinuation (DR)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Overall (not specified)
Number of subjects: 103
Study: 35439878

Group type: EXPERIMENTAL
Intervention: Lollipops containing xylitol and erythritol
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (without lollipops)
Number of subjects: 50
Study: 33446240

Group type: EXPERIMENTAL
Intervention: Proband, duo, or trio whole‐genome sequencing and proband targeted gene panels
Number of subjects: 1130

Group type: EXPERIMENTAL
Intervention: Digital platform (GUÍA) for returning genomic results
Number of subjects: 1130

Group type: EXPERIMENTAL
Intervention: Surveys at baseline (0 months), result disclosure visit (+3 months), and follow‐up visit (+9 months)
Number of subjects: 1130

Group type: EXPERIMENTAL
Intervention: GenomeDiver digital tool
Number of subjects: 1130
Study: 32450344

Group type: EXPERIMENTAL
Intervention: Tirofiban (25 μg/Kg as bolus infusion, followed by 0.15 μg/Kg/min continuous infusion for 48 hours), acetylsalicylic acid (250 mg infusion and 75 mg daily for 30 days), clopidogrel (300 mg oral and 75 mg daily for 30 days), fondaparinux (2.5 mg/day subcutaneous for duration of hospital stay)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control group receiving prophylactic or therapeutic dose heparin
Number of subjects: 5
Study: 36288582

Group type: EXPERIMENTAL
Intervention: Anteroposterior (AP) view
Number of subjects: 204

Group type: COMPARATOR
Intervention: Oblique (OB) view
Number of subjects: 204
Study: 33668679

Group type: EXPERIMENTAL
Intervention: Urine autofluorescence at 295 nm in patients with malignant melanoma
Number of subjects: 0
Study: 35042187

Group type: EXPERIMENTAL
Intervention: Whey Protein (WP)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Leucine-Matched Collagen Peptides (CP)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both WP and CP
Number of subjects: 22
Study: 34737469

Group type: EXPERIMENTAL
Intervention: Water and sanitation infrastructure and hygiene promotion intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 40
Study: 32398324

Group type: EXPERIMENTAL
Intervention: Olaparib 300 mg twice daily and durvalumab 1,500 mg intravenously every 4 weeks until disease progression, unacceptable toxicity, or withdrawal of consent.
Number of subjects: 35
Study: 35669374

Group type: EXPERIMENTAL
Intervention: Intelligent delivery room management system
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard obstetric care
Number of subjects: 100
Study: 34325550

Group type: EXPERIMENTAL
Intervention: Progressive web application (PWA) education
Number of subjects: 52

Group type: COMPARATOR
Intervention: Verbal instructions with demonstration
Number of subjects: 52
Study: 33040584

Group type: EXPERIMENTAL
Intervention: Worsened symptom classification (increased Rutherford classification)
Number of subjects: 12759

Group type: COMPARATOR
Intervention: No change in symptom classification (stable Rutherford classification)
Number of subjects: 12759

Group type: EXPERIMENTAL
Intervention: Improved symptom classification (decreased Rutherford classification)
Number of subjects: 12759
Study: 36435798

Group type: EXPERIMENTAL
Intervention: Molnupiravir
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study: 33302143

Group type: EXPERIMENTAL
Intervention: Multidose DPI
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: MDI
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: No knowledge about COPD
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Inhaler effectiveness perceived as fair/poor
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Intermediate/poor adherence
Number of subjects: 318
Study: 33059419

Group type: EXPERIMENTAL
Intervention: Group A (corneal diameter ≤ 11.1 mm)
Number of subjects: 6744

Group type: EXPERIMENTAL
Intervention: Group B (corneal diameter 11.2 to 11.8 mm)
Number of subjects: 6744

Group type: COMPARATOR
Intervention: Group C (corneal diameter ≥ 11.9 mm)
Number of subjects: 6744
Study: 35262715

Group type: EXPERIMENTAL
Intervention: Cisplatin plus pemetrexed (MPS)
Number of subjects: 1501

Group type: EXPERIMENTAL
Intervention: Cisplatin plus pemetrexed plus bevacizumab (MAPS)
Number of subjects: 1501

Group type: EXPERIMENTAL
Intervention: Nivolumab plus ipilimumab (CM743)
Number of subjects: 1501
Study: 35189734

Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 1
Study: 32412858

Group type: EXPERIMENTAL
Intervention: Medtronic MiniMed™ 640G Suspend before low feature
Number of subjects: 0
Study: 35915956

Group type: EXPERIMENTAL
Intervention: Wet-suction (WS) technique
Number of subjects: 210

Group type: COMPARATOR
Intervention: Slow-pull (SP) technique
Number of subjects: 210
Study: 33862350

Group type: EXPERIMENTAL
Intervention: 5% pomegranate peel extract solution used with a pulsating jet irrigator
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 34
Study: 36431314

Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal therapy (TG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Mechanical plaque removal (CG)
Number of subjects: 30
Study: 32030624

Group type: EXPERIMENTAL
Intervention: Inguinal approach for obturator nerve block
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravesical approach for obturator nerve block
Number of subjects: 0
Study: 35206569

Group type: EXPERIMENTAL
Intervention: Aerobic intervention for 12 weeks, three times a week, in 45-min sessions
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (CFS) maintained their daily routines as normal
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Aerobic intervention
Number of subjects: 46
Study: 33582975

Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Contemporary methods (Mendelian randomization and pharmaco-epidemiological research)
Number of subjects: 0
Study: 33563509

Group type: EXPERIMENTAL
Intervention: Neuromobilization techniques (6-week conservative rehabilitation and radial nerve mobilization program)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conservative rehabilitation therapy only (control group)
Number of subjects: 40
Study: 34429197

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination of rosuvastatin 2.5 mg and ezetimibe 10 mg (R2.5+E10)
Number of subjects: 279

Group type: COMPARATOR
Intervention: Ezetimibe 10 mg monotherapy (E10)
Number of subjects: 279

Group type: COMPARATOR
Intervention: Rosuvastatin 2.5 mg (R2.5)
Number of subjects: 279

Group type: COMPARATOR
Intervention: Rosuvastatin 5 mg monotherapy (R5)
Number of subjects: 279
Study: 33143722

Group type: EXPERIMENTAL
Intervention: Intermittent use of a fasting-mimicking diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 35357066

Group type: EXPERIMENTAL
Intervention: Low-fat diet (LFD)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Mediterranean diet (MedDiet)
Number of subjects: 42
Study: 33477003

Group type: EXPERIMENTAL
Intervention: Mindfulness for Multiple Sclerosis (M4MS)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Chair Yoga
Number of subjects: 55

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 55
Study: 32410652

Group type: EXPERIMENTAL
Intervention: Oral food challenge (OFC)
Number of subjects: 4151

Group type: EXPERIMENTAL
Intervention: Skin prick test (SPT) and specific IgE (sIgE) measurement
Number of subjects: 4151

Group type: EXPERIMENTAL
Intervention: Parent-reported food allergy
Number of subjects: 4151

Group type: EXPERIMENTAL
Intervention: Overall prevalence of food allergy
Number of subjects: 4151

Group type: EXPERIMENTAL
Intervention: Common allergic manifestations
Number of subjects: 4151

Group type: EXPERIMENTAL
Intervention: Common allergic foods
Number of subjects: 4151
Study: 35413887

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI)‐style chatbot (n=78)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Neutral chatbot (n=75)
Number of subjects: 153
Study: 32130661

Group type: EXPERIMENTAL
Intervention: Basal insulin-based treatment (insulin glargine plus OADs)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Twice-daily premixed insulin (NovoLog® Mix 70/30)
Number of subjects: 400
Study: 35505122

Group type: EXPERIMENTAL
Intervention: Aged garlic extract (AGE) 2.4 g
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Aged garlic extract (AGE)
Number of subjects: 28
Study: 32686262

Group type: EXPERIMENTAL
Intervention: Autologous skin cell suspension (ASCS) in combination with standard therapy
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Health-related Quality of Life questionnaire
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Satisfaction scores from subjects and clinicians
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Safety outcomes
Number of subjects: 16
Study: 34225479

Group type: EXPERIMENTAL
Intervention: Multi-channeled nutrition education approach (both OFSP-branded materials for preschoolers and mobile phone mediated text messages for caregivers)
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Single-channeled nutrition education approach (OFSP-branded materials for preschoolers only)
Number of subjects: 431

Group type: EXPERIMENTAL
Intervention: Single-channeled nutrition education approach (mobile phone mediated text messages for caregivers only)
Number of subjects: 431

Group type: COMPARATOR
Intervention: Control group (routine OFSP promotion activities)
Number of subjects: 431
Study: 32437307

Group type: EXPERIMENTAL
Intervention: Genetic insights and shared genetic loci between T2D and CHD
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mendelian randomization studies assessing whether T2D is causal for CHD
Number of subjects: 0
Study: 36221306

Group type: EXPERIMENTAL
Intervention: START-Play intervention
Number of subjects: 112

Group type: COMPARATOR
Intervention: Usual care - early intervention
Number of subjects: 112
Study: 33969933

Group type: EXPERIMENTAL
Intervention: Atypical category
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Malignant category
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Atypical and suspicious for malignancy categories
Number of subjects: 12
Study: 36691242

Group type: EXPERIMENTAL
Intervention: Mental imagery audioguide session
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Part-task trainer simulation
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: Written instructions
Number of subjects: 309
Study: 33044432

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine
Number of subjects: 214

Group type: COMPARATOR
Intervention: Control (standard protocol without N-acetylcysteine)
Number of subjects: 214
Study: 36446888

Group type: EXPERIMENTAL
Intervention: Preterm donor human milk (DHM)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Term donor human milk (DHM)
Number of subjects: 102
Study: 33857201

Group type: EXPERIMENTAL
Intervention: Intermittent hypoxia group (nondependent lung not ventilated for 2 min, then ventilated for 2 min, repeated five times)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Continuous normoxia group (both lungs ventilated for 20 min)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Intermittent hypoxia group
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 136
Study: 35724966

Group type: EXPERIMENTAL
Intervention: Drinks:Ration mobile app
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control mobile app (government guidance only)
Number of subjects: 123
Study: 32156749

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (PGH arm)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Gemcitabine and nab-paclitaxel (PG arm)
Number of subjects: 64
Study: 36199101

Group type: EXPERIMENTAL
Intervention: HMD‐VR
Number of subjects: 36

Group type: COMPARATOR
Intervention: CS
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: HMD‐VR to CS
Number of subjects: 36
Study: 34120616

Group type: EXPERIMENTAL
Intervention: Behavioural arm providing information about the child’s possible emotions and behaviour during and after admission, and providing age appropriate games for the caregiver and child.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Psycho-educational arm providing information about hospital procedures during admission.
Number of subjects: 120
Study: 32695822

Group type: EXPERIMENTAL
Intervention: EVD weaning trial with monitoring of intracranial pressure (ICP)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: EVD weaning trial with ICP burden above 20 mmHg
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Receiver operating characteristic analyses for delta ICP
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Receiver operating characteristic analyses for ICP burden >20 mmHg
Number of subjects: 37
Study: 36222863

Group type: EXPERIMENTAL
Intervention: Intermittent hypoxia (three 4-min hypoxic cycles at 80% arterial oxygen saturation interspersed with 4-min room air cycles)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Intermittent normoxia (three 4-min normoxic cycles separated by 4-min room air cycles)
Number of subjects: 12
Study: 33089537

Group type: EXPERIMENTAL
Intervention: Self-management support intervention (8 sessions over 4 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 40
Study: 32719355

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33783059

Group type: EXPERIMENTAL
Intervention: Cognitive Remediation (CR) plus Treatment as Usual (TAU)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 65
Study: 33902655

Group type: EXPERIMENTAL
Intervention: Online questionnaire administration
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Clinical measurements (strength and range of motion, mid‐foot mobility, palpation, ultrasound assessment of plantar fascia)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Ultrasound assessment of plantar fascia
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Graded loading challenge
Number of subjects: 36
Study: 616952074

Group type: EXPERIMENTAL
Intervention: Intravenous administration of paracetamol 1000mg
Number of subjects: 34

Group type: COMPARATOR
Intervention: Oral administration of paracetamol 1000mg
Number of subjects: 34
Study: 36255178

Group type: EXPERIMENTAL
Intervention: Verum acupuncture
Number of subjects: 70

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 70
Study: 33969764

Group type: EXPERIMENTAL
Intervention: Paravertebral intramuscular Ozone injection
Number of subjects: 30

Group type: COMPARATOR
Intervention: Caudal epidural steroid-hyaluronidase injection
Number of subjects: 30
Study: 32384905

Group type: EXPERIMENTAL
Intervention: Foot exercise plus education
Number of subjects: 20

Group type: COMPARATOR
Intervention: Brief advice
Number of subjects: 20
Study: 35765018

Group type: EXPERIMENTAL
Intervention: PACE intervention
Number of subjects: 61

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 61
Study: 32926540

Group type: EXPERIMENTAL
Intervention: Biomarker panel for dietary exposure assessment
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Quantitative relationships between biomarker concentrations
Number of subjects: 34
Study: 34970741

Group type: EXPERIMENTAL
Intervention: Subcutaneous low molecular weight heparin (LMWH) injection after coolant spray application in the leg region
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Subcutaneous low molecular weight heparin (LMWH) injection after coolant spray application in the abdominal region
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Subcutaneous low molecular weight heparin (LMWH) injection after coolant spray application in the arm region
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Subcutaneous low molecular weight heparin (LMWH) injection after coolant spray application in the abdominal and arm regions
Number of subjects: 50
Study: 33518395

Group type: EXPERIMENTAL
Intervention: Inpatient single-agent regimen (Group A): cefazolin sodium 1g preoperatively and every eight hours for 48 hours postoperatively
Number of subjects: 100

Group type: COMPARATOR
Intervention: Extended dual-agent regimen (Group B): cefazolin sodium 1g preoperatively and every eight hours for 48 hours postoperatively, followed by oral amoxicillin for three days
Number of subjects: 100
Study: 36259684

Group type: EXPERIMENTAL
Intervention: Duloxetine supplemented with pregabalin
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Pregabalin supplemented with amitriptyline
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Combination therapy (weeks 6-16)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Amitriptyline supplemented with pregabalin
Number of subjects: 140
Study: 33588408

Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP) or other interventions for sleep apnea (exact dosage and duration not specified)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Renal transplantation
Number of subjects: 0
Study: 33118908

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT) delivered by trained lay health workers; 8 sessions
Number of subjects: 50

Group type: COMPARATOR
Intervention: Care as Usual (CAU)
Number of subjects: 50
Study: 35787522

Group type: EXPERIMENTAL
Intervention: Inhaled treprostinil
Number of subjects: 792

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 792
Study: 34052065

Group type: EXPERIMENTAL
Intervention: 20 µg recombinant hepatitis B vaccine (IM20 group)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: 60 µg recombinant hepatitis B vaccine (IM60 group)
Number of subjects: 182